IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q1 2016 Holdings

Filed 2016-05-13 | 6 holdings | $133.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Entellus MED IncCOM29363K105$63.5K3,489,53347.4%
Transenterix IncCOM NEW89366M201$32.1K7,546,69224.0%
Ocular Therapeutix Inc(OCUL)COM67576A100$18.7K1,932,60713.9%
Catabasis Pharmaceuticals inCOM14875P107$14.4K2,857,66710.8%
Raptor Pharmaceutical CorpCOM75382F106$4.1K888,1323.1%
Lombard MED IncCOMG55598109$1.1K1,077,4990.8%